SCHEMBL13725910

SCHEMBL13725910

Brc1ccc(-c2cccc3c2C2c4ccccc4C3c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 5/20 0.39
GAA P10253 3/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CYP1A2 P05177 1/20 0.39
PLK4 O00444 1/20 0.38
AURKA O14965 1/20 0.38
JAK2 O60674 1/20 0.38
LCK P06239 1/20 0.38
CDK1 P06493 1/20 0.38
CSF1R P07333 1/20 0.38
LYN P07948 1/20 0.38
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38
MARK3 P27448 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27947294 0.76 MEN1 (0.42) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL22272286 0.75 MAPK1 (0.38) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL27880163 0.73 KMT2A (0.46) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL7522172 0.72 ALDH1A1 (0.63) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL19125933 0.72 ALDH1A1 (0.63) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL25118992 0.71 MEN1 (0.44) MAPK1ALDH1A1GAAMEN1KMT2A
SCHEMBL31746992 0.71 MEN1 (0.44) MAPK1ALDH1A1GAAMEN1KMT2A
SCHEMBL13951873 0.71 MEN1 (0.40) MAPK1ALDH1A1NPC1GAAMEN1
SCHEMBL4022049 0.71 HTR2A (0.46) MAPK1ALDH1A1GAAMEN1KMT2A
SCHEMBL18926276 0.69 NPC1 (0.55) MAPK1ALDH1A1NPC1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO. LTD. (JP) 2009-08-13 US disclosed
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO. LTD. (JP) 2009-08-13 US disclosed
US-7504526-B2 Anthracene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-03-17 US disclosed
US-7504526-B2 Anthracene derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2009-03-17 US disclosed
EP-1754696-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-02-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200929-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME ALKBH2, ANXA7, ANXA2 MAPK1 1942/4885ALDH1A1 130/4885NPC1 4477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.